Immunoproteasome as a therapeutic target in obesity-related brain inflammation and metabolic disorders

Immunoproteasome as a therapeutic target in obesity-related brain inflammation and metabolic disorders

Saved in:

Bibliographic Details
Main Authors:	Javiera Álvarez-Indo, Nicolás Albornoz, Andrea Soza, Patricia V. Burgos
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-04-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-01358
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

From oncogenesis to prognosis: the roles of the immunoproteasome in cancer
by: Delphine Béland, et al.
Published: (2025-07-01)

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
by: Hiroaki Kimura, et al.
Published: (2015-01-01)

CGRPβ suppresses the pathogenesis of ulcerative colitis via the immunoproteasome
by: Tatsuya Shibao, et al.
Published: (2025-02-01)

Immunoproteasome Inhibition Impairs Differentiation but Not Survival of T Helper 17 Cells
by: Franziska Oliveri, et al.
Published: (2025-05-01)

Impaired immunoproteasomal function exacerbates renal ischemia-reperfusion injury
by: Yasushi Ishii, et al.
Published: (2024-12-01)

Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
by: Daniela Sorriento, et al.
Published: (2014-01-01)

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
by: Nadine Althof, et al.
Published: (2018-01-01)

A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.
by: Sarah Hutchinson, et al.
Published: (2011-02-01)

OBESITY, INFLAMMATION, AND T-CELL METABOLISM
by: K. Hristov
Published: (2019-12-01)

Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.
by: Hiroshi Wada, et al.
Published: (2018-01-01)

Recent Advances in the Development of Immunoproteasome Inhibitors as Anti-Cancer Agents: The Past 5 Years
by: Francesca Mancuso, et al.
Published: (2025-02-01)

Retracted: Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
by: The Scientific World Journal
Published: (2019-01-01)

Ferroptosis as a potential therapeutic target for obesity-related metabolic diseases
by: Chao-Dong Huang, et al.
Published: (2025-07-01)

Chronic Inflammation in Obesity and the Metabolic Syndrome
by: Rosário Monteiro, et al.
Published: (2010-01-01)

Targeting Immunoproteasome in Polarized Macrophages Ameliorates Experimental Emphysema Via Activating NRF1/2‐P62 Axis and Suppressing IRF4 Transcription
by: Bingxin Guo, et al.
Published: (2024-11-01)

Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications
by: Antonio Macciò, et al.
Published: (2011-01-01)

Lipotoxicity and metabolic disorders at obesity
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

Inflammation as a Link between Obesity and Metabolic Syndrome
by: Faloia Emanuela, et al.
Published: (2012-01-01)

Brain Glucose Hypometabolism and Brain Iron Accumulation as Therapeutic Targets for Alzheimer’s Disease and Other CNS Disorders
by: Indira Y. Rao, et al.
Published: (2025-02-01)

Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents
by: Azura Murphy, et al.
Published: (2025-03-01)

Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes
by: Shuang Chen, et al.
Published: (2016-01-01)

Metabolic and endocrine disorders in obesity in dogs
by: V. V. Horiuk, et al.
Published: (2025-03-01)

Atherosclerosis and inflammation: therapeutic targets and ways of correction
by: A. A. Klimenko, et al.
Published: (2024-06-01)

Extracellular Traps in Inflammation: Pathways and Therapeutic Targets
by: Stelvio Tonello, et al.
Published: (2025-04-01)

Therapeutic Targets and Approaches to Manage Inflammation of NAFLD
by: Wanying Geng, et al.
Published: (2025-02-01)

Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration
by: Jialiu Zeng, et al.
Published: (2025-01-01)

Ameliorative Effects of Polygonatum kingianum Polysaccharides on Lipid Metabolism Disorders and Brain Function Impairments in Obese Mice
by: XU Yuncong, YAN Qiaojuan, ZHU Chunhua, YANG Shaoqing, LI Houjiang, JIANG Zhengqiang
Published: (2025-01-01)

Microbial melatonin metabolism in the human intestine as a therapeutic target for dysbiosis and rhythm disorders
by: Petra Zimmermann, et al.
Published: (2024-11-01)

AMPK in Intestinal Health and Disease: A Multifaceted Therapeutic Target for Metabolic and Inflammatory Disorders
by: Yibcharoenporn C, et al.
Published: (2025-04-01)

Downregulation of the immunoproteasome subunit PSMB8 attenuates sepsis-associated acute kidney injury through the NF-κB pathway
by: Min Li, et al.
Published: (2025-01-01)

EXPRESSION OF GENES ENCODING IMMUNOPROTEASOME SUBUNITS INDUCIBLE BY MACROPHAGES INFECTED WITH M. bovis BGC AND M. Tuberculosis H37RV
by: S. N. Andreevskaya, et al.
Published: (2014-02-01)

Sleep disorders and carbohydrate metabolism in obese patients
by: N V Strueva, et al.
Published: (2013-09-01)

The endocannabinoidome–gut microbiome–brain axis as a novel therapeutic target for autism spectrum disorder
by: Antonella Campanale, et al.
Published: (2025-07-01)

Lipid Metabolism as a Therapeutic Target
by: Terry K. Smith, et al.
Published: (2012-01-01)

THE RELATIONSHIP BETWEEN METABOLIC DISORDERS AND TUMOR PROGRESSION: REVIEW OF PRESENT DATA AND NEW THERAPEUTIC TARGETS
by: E. V. Semina, et al.
Published: (2021-08-01)

Brown adipose tissue: a potential therapeutic target for preventing cardiovascular disease in metabolic disorders
by: Tamara Egan Beňová, et al.
Published: (2025-08-01)

The Mechanisms of Chronic Inflammation in Obesity and Potential Therapeutic Strategies: A Narrative Review
by: Elvira Meni Maria Gkrinia, et al.
Published: (2025-05-01)

Non-hematopoietic roles of erythropoietin in inflammation and metabolic disorders
by: Satoru Sugimoto, et al.
Published: (2025-07-01)

Regulatory factors of ILC2 are therapeutic targets for lung inflammation
by: Lele Cui, et al.
Published: (2024-09-01)

INFLAMMATION AS A THERAPEUTIC TARGET IN THE COMPLEX TREATMENT OF MALIGNANT TUMORS
by: O. E. Savelieva, et al.
Published: (2017-07-01)